Cargando…
Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515431/ https://www.ncbi.nlm.nih.gov/pubmed/36212907 http://dx.doi.org/10.1016/j.omtm.2022.09.003 |
| _version_ | 1784798479089926144 |
|---|---|
| author | Engeland, Christine E. |
| author_facet | Engeland, Christine E. |
| author_sort | Engeland, Christine E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9515431 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Gene & Cell Therapy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-95154312022-10-06 Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine Engeland, Christine E. Mol Ther Methods Clin Dev Commentary American Society of Gene & Cell Therapy 2022-09-24 /pmc/articles/PMC9515431/ /pubmed/36212907 http://dx.doi.org/10.1016/j.omtm.2022.09.003 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Commentary Engeland, Christine E. Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title | Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title_full | Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title_fullStr | Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title_full_unstemmed | Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title_short | Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| title_sort | safety study supports clinical development of immunotherapeutic oncolytic measles vaccine |
| topic | Commentary |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515431/ https://www.ncbi.nlm.nih.gov/pubmed/36212907 http://dx.doi.org/10.1016/j.omtm.2022.09.003 |
| work_keys_str_mv | AT engelandchristinee safetystudysupportsclinicaldevelopmentofimmunotherapeuticoncolyticmeaslesvaccine |